Vitamin A family compounds, estradiol, and docetaxel in proliferation, apoptosis and immunocytochemical profile of human ovary endometrioid cancer cell line CRL-11731

Folia Histochemica et Cytobiologica

Volumn 47, Issue 5, 2009, Pages

  Czeczuga Semeniuk, Ewa ^a   Bielawski, Tomasz ^a   Lemancewicz, Dorota ^a   Rusak, Małgorzata ^a   Wołczyński, Sławomir ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Apoptosis; CRL 11731; Docetaxel; Estradiol; Proliferation; Vitamin A

Indexed keywords

BETA CAROTENE; CAROTENOID; CYCLINE; DOCETAXEL; ESTRADIOL; KI 67 ANTIGEN; LYCOPENE; PROTEIN BCL 2; PROTEIN P53; RETINOIC ACID; RETINOID; RETINOL; TAMOXIFEN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; DRUG EFFECT; ENDOMETRIOID CARCINOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; BREAST TUMOR; CELL DIVISION; CELL LINE; DRUG EFFECTS; FEMALE; METABOLISM; OVARY; TUMOR CELL CULTURE;

APOPTOSIS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE; CELL PROLIFERATION; ESTRADIOL; FEMALE; HUMANS; OVARY; TAMOXIFEN; TUMOR CELLS, CULTURED; VITAMIN A;

EID: 75949105561     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-009-0052-9     Document Type: Article

References (45)

1. World Health Organization Classification of Tumors, Pathology and Genetics of Tumors of the Breast and Female Genital Organs. Tavassoli FA, Devile P, eds, IARC Press; Lyon; 2003.
2. Tagashira Y, Shimada M, Kigawa J, Iba T, Terakawa N. Ovarian endometrioid adenocarcinoma arising from endometriosis in a young woman. Gynecol Oncol. 2003;91:643-647.
3. Campbell IG, Morland S, Hitchcock A. Endometriosis and the relationship with ovarian cancer. In: Sharp F, Blackett T, Derek J, Bast R, eds. Ovarian cancer 5. Oxford: ISIS Medical Media; 1998:159-170.
4. Catasús L, Bussaglia E, Rodrguez I et al. Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas. Hum Pathol. 2004;35:1360-1368.
5. Wang V, Li C, Lin M et al. Ovarian cancer is a heterogeneous disease. Cancer Genet Cytogenet. 2005;161:170-173.
6. Kawaguchi R, Tsuji Y, Haruta S et al. Clinicopathologic features of ovarian cancer in patients with ovarian endometrioma. J Obstet Gynaecol Res. 2008;34(5):872-887
7. Ozols RF. Systemic therapy for ovarian cancer: current status and new treatments. Semin Oncol. 2006;33:S3-S11.
8. Watanabe Y, Tsuchiya H, Sakabe T et al. CD437 induces apoptosis in ovarian adenocarcinoma cells via ER stress signaling. Biochem Biophys Res Commun. 2008; 366:840-847.
9. Zhang D, Holmes WF, Wu S, et al. Retinoids and ovarian cancer. J Cell Physiol.2000;185:1-20.
10. Morita Y, Tilly JL. Segregation of retinoic acid effects on fetal ovarian germ cell mitosis versus apoptosis by requirement for new macromolecular synthesis. Endocrinology. 1999;140: 2696-2703.
11. Grunt TW, Puckmair K, Tomek K, Kainz B, Gaiger A. An EGF receptor inhibitor induces RAR-beta expression in breast and ovarian cancer cells. Biochem Biophys Res Commun. 2005;329:1253-1259.
12. Smith TA. Carotenoids and cancer: Prevention and potential therapy. Br J Biomed Sci. 1998;55:268-275.
13. Peng YM, Peng YS, Childers JM et al. Concentrations of carotenoids, tocopherols, and retinol in paired plasma and cervical tissue of patients with cervical cancer, precancer, and noncancerous diseases. Cancer Epidemiol Biomarkers Prev. 1998;7:347-350.
14. Yeum KJ, Ahn SH, Rupp de Paiva SA, Lee-Kim YC, Krinsky NI, Russell RM. Correlation between carotenoid concentrations in serum and normal breast adipose tissue of women with benign breast tumor or breast cancer. J Nutr. 1998;128:1920-1926.
15. Schweigert FJ, Zucker H. Concentrations of vitamin A, hcarotene and vitamin E in individual bovine follicles of different quality. J Reprod Fertil.1988;82:575-579.
16. Stahl W, Sies H. Lycopene: a biologically important carotenoid for humans? Arch Biochem Biophys. 1996;336:1-9.
17. Czeczuga-Semeniuk E, Wolczyñski S. Identification of carotenoids in ovarian tissue in women. Oncol Rep. 2005;14:1385-1392.
18. Czeczuga-Semeniuk E, Wołczyñski S. Does the variability in carotenoid composition and concentration in tissues of breast and reproductive tract in women depend on the type of lesion? Adv Med Sci. 2008;53:270-277.
19. Wu S, Donigan A, Platsoucas CD, Jung W, Soprano DR, Soprano KJ. All-trans-retinoic acid blocks cell cycle progression of human ovarian adenocarcinoma cells at late G1. Exp Cell Res. 1997;232:277-286.
20. Kalli KR, Devine KE, Cabot MC et al. Heterogeneous role of caspase-8 in fenretinide-induced apoptosis in epithelial ovarian carcinoma cell lines. Mol Pharmacol. 2003;64:1434-1443.
21. Kaplan LA, Lau JM, Stein EA. Carotenoid composition, concentrations, and relationships in various human organs. Clin Physiol Biochem. 1990;8:1-10.
22. Stahl W, Schwarz W, Sundquist AR, Sies H. cis-trans isomers of lycopene and β-carotene in human serum and tissues. Arch Biochem Biophys. 1992;294:173-177.
23. Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Method Enzymol. 1990;186:1-85.
24. Wang Q, Wieder R. All-trans retinoic acid potentiates Taxotere induced cell death mediated by Jun N-terminal kinase in breast cancer cells. Oncogene. 2004;23:426-433.
25. Subbaramaiah K, Hart J, Norton L, Dannenberg A. Microtubule-interfering agents stimulate the transcription of cyclooxygenase-2. Evidence for involvement of ERK1/2 AND p38 mitogen-activated protein kinase pathways. J Biol Chem. 2000;275:14838-14845.
26. McDaid H, Lopez-Barcons L, Grossman A, Lia M. Enhancement of the therapeutic efficacy of Taxol by the mitogenactivated protein kinase kinase inhibitor CI1040 in nude mice bearing human heterotransplants. Cancer Res. 2005;65:2854-2860.
27. Caliaro MJ, Vitaux P, Lafon C et al. Multifactorial mechanism for the potentiation of cisplatin (CDDP) cytotoxicity by alltrans retinoic acid (ATRA) in human ovarian carcinoma cell lines. Br J Cancer.1997;75:333-340.
28. Smith JA, Ngo H, Martin MC, Wolf JK. An evaluation of cytotoxicity of the taxane and platinum agents combination treatment in a panel of human ovarian carcinoma cell lines. Gynecol Oncol. 2005;98:141-145.
29. Holmes WF, Soprano DR, Soprano KJ. Elucidation of molecular events mediating induction of apoptosis by synthetic retinoids using a CD437-resistant ovarian carcinoma cell line. J Biol Chem. 2002;277:45408-45419.
30. Holmes WF, Soprano DR, Soprano KJ. Early events in the induction of apoptosis in ovarian carcinoma cells by CD437: activation of the p38 MAP kinase signal pathway. Oncogene. 2003;22:6377-6386.
31. Basu A, Haldar S. The relationship between Bcl2, Bax and p53: consequences for cell cycle progression and cell death. Mol Hum Reprod. 1998;4:1099-1109.
32. Wang X. The expanding role of mitochondria in apoptosis. Gene Dev. 2001;15:2922-2933.
33. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science.1998;281:1305-1308.
34. Ghahremani M, Foghi A, Dorrington JH. Etiology of ovarian cancer: A proposed mechanism. Med Hypotheses. 1999;52: 23-26.
35. Vuocolo S, Purev E, Zhang D et al. Protein phosphatase 2A associates with Rb2/p130 and mediates retinoic acid-induced growth suppression of ovarian carcinoma cells. J Biol Chem. 2003;278:41881-41889.
36. Mehta K. Retinoids as regulators of gene transcription. J Biol Regul Homeost Agents. 2003;17:1-12.
37. Crowe DL, Kim R, Chandraratna RA. Retinoic acid differentially regulates cancer cell proliferation via dose-dependent modulation of the mitogen-activated protein kinase pathway. Mol Cancer Res. 2003;1:532-540.
38. Nehmé A, Varadarajan P, Sellakumar G et al. Modulation of docetaxel-induced apoptosis and cell cycle arrest by all-trans retinoic acid in prostate cancer cells. Brit J Cancer. 2001;84:1571-1576.
39. Miyashita T, Krajewski S, Krajewska M et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 1994;9:1799-1805.
40. Kagawa S, Fujiwara T, Hizuta A et al. p53 expression overcomes p21WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells. Oncogene. 1997;15:1903-1909.
41. Tartier L, McCarey YL, Biaglow JE, Kochevar IE, Held KD. Apoptosis induced by dithiothreitol in HL-60 cells shows early activation of caspase 3 and is independent of mitochondria. Cell Death Differ. 2000;7:1002-1010.
42. Dai L, Li C, Shedden KA, Misek DE, Lubman DM. Comparative proteomic study of two closely related ovarian endometrioid adenocarcinoma cell lines using cIEF fractionation and pathway analysis. Electrophoresis. 2009;30,1-13.
43. Langdon SP, Hirst GL, Miller EP et al. The regulation of growth and protein expression by estrogen in vitro: a study of 8 human ovarian carcinoma cell lines. J Steroid Biochem Mol Biol. 1994;50:131-135.
44. Bardin A, Hoffmann P, Boulle N et al. Involvement of estrogen receptor beta in ovarian carcinogenesis. Cancer Res. 2004;64:5861-5869.
45. Rutherford T, Brown WD, Sapi E, Aschkenazi S, Munoz A, Mor G. Absence of estrogen receptor-beta expression in metastatic ovarian cancer. Obstet Gynecol. 2000;96:417-421.